版本:
中国

BRIEF-Nature Cell receives FDA approval for early and mid-stage alzheimer's clinical trial

Nov 28 Nature Cell Co Ltd -

* Nature Cell Co Ltd receives U.S. FDA approval for phase I and II alzheimer's clinical trial

* Announces Astrostem's approval for phase i and phase ii clinical trials for treatment of alzheimer's disease by U.S. FDA on November 23 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐